Immunocore Holdings plc (FRA:6YG)
Germany · Delayed Price · Currency is EUR 24.00
-1.00 (-4.00%)
Last updated: Jun 3, 2026, 7:55 PM CET
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of €1.29 billion as of June 3, 2026. Its market cap has decreased by -5.67% in one year.
Market Cap
1.29B
Enterprise Value
939.85M
Revenue
358.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
€24.00
Market Cap Chart
Since February 5, 2021, Immunocore Holdings's market cap has decreased from 1.49B to 1.29B, a decrease of -13.51%. That is a compound annual growth rate of -2.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 1.29B | -13.56% |
| Dec 31, 2025 | 1.49B | 4.78% |
| Dec 31, 2024 | 1.43B | -53.35% |
| Dec 29, 2023 | 3.06B | 19.45% |
| Dec 30, 2022 | 2.56B | 93.80% |
| Dec 31, 2021 | 1.32B | -11.59% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.27B |
| Darwin AG | 72.00M |
| 2invest AG | 45.07M |
| Biomark Diagnostics | 36.15M |
| Vidac Pharma Holding | 29.43M |
| Paion AG | 403.05K |
| co.don AG | 347.40K |
| bioXXmed AG | 217.49K |